A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...

Systems has optimized key device and treatment parameters including frequency, amplitude, electrode positioning, and duration ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...

In January 2024, Matisse reported positive topline results from the HistoSeps trial, which was designed to evaluate the ...

Produced by ABC Global Alliance and VML Health, the study reveals progress and ongoing gaps in care, treatment and outcomes.

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...